about
Metabolomics: A Tool Ahead for Understanding Molecular Mechanisms of Drugs and DiseasesApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureMetabolomics enables precision medicine: "A White Paper, Community Perspective"Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients.Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Improved motor and cognitive performance with sodium nitrite supplementation is related to small metabolite signatures: a pilot trial in middle-aged and older adultsEffects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-aged and older adults.Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.Emerging applications of metabolomics in drug discovery and precision medicine.Circadian regulation of lipid metabolism.Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics.Managing the innovation supply chain to maximize personalized medicine.Pharmacometabolomic signature links simvastatin therapy and insulin resistance.
P2860
Q26827107-F02D302E-814F-462B-BC1D-03547539DF1BQ28074451-765EDC6C-71FC-4666-A3DD-0D81AE3F5461Q28831476-B317ED1D-C9D9-40B8-A8BE-DB1A06F0718AQ33687277-6B7B911F-54F4-4FE6-9DBB-C11B37314CA4Q35032056-8E31A0DB-3555-4B3A-9ECF-ED616C3A68B0Q36411120-8557F3A0-9876-4737-9256-F0F98BB66A31Q36582992-5DD8D938-31F6-475C-BA88-B037DEFD8807Q37078812-ACC54567-456B-4289-B11C-66C872163E14Q37457684-DE2EB745-5409-4700-A023-285B9F5B4461Q37512208-C505FA2F-63AA-4DFB-8AA3-3805975E258CQ38769103-D059D06A-85EC-484A-9F29-F651E3E1918BQ38844421-97698BC3-F007-40BD-B3B6-176CA1AD1FADQ41870452-F7676D8F-AB51-48A9-AB2E-4E14792F982FQ51121488-010EFD4B-2D58-4E41-96E3-EA3E916C67BBQ53755580-EBDD7281-8F81-4E04-96EB-9A77DDC9A631
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacometabolomics of statin response
@ast
Pharmacometabolomics of statin response
@en
type
label
Pharmacometabolomics of statin response
@ast
Pharmacometabolomics of statin response
@en
prefLabel
Pharmacometabolomics of statin response
@ast
Pharmacometabolomics of statin response
@en
P2860
P356
P1476
Pharmacometabolomics of statin response
@en
P2093
P2860
P304
P356
10.1038/CLPT.2013.164
P407
P577
2013-08-14T00:00:00Z